Annual EBITDA
$607.80M$81.20M+15.42%
Summary
- Current Value
- As of today, SGRY annual EBITDA is $607.80M, up +15.42% on
- Historical Performance
- SGRY annual EBITDA is up +42.51% over the past 3 years, and up +61.99% over the past 5 years
- All-Time High Comparison
- SGRY annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SGRY annual EBITDA is +19.76% above its 3-year low of $507.50M reached on an earlier date
- Sector Comparison
- SGRY annual EBITDA is higher than 92.27% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $607.80M | +15.4% | +42.5% | +62.0% | +738.0% | |
| Quarterly EBITDA | $172.90M | +16.6% | +40.6% | +75.9% | +797.3% | |
| TTM EBITDA | $655.90M | +12.7% | +38.8% | +106.8% | +3303.7% | |
| Price | $16.12 | -24.1% | -43.6% | -46.8% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $3.11B | +13.5% | +40.0% | +70.0% | +1096.8% | |
| Annual EPS | -$1.33 | -1307.4% | -18.9% | +41.8% | -3448.7% | |
| Annual EBIT | $454.30M | +11.2% | +57.4% | +75.6% | +640.8% | |
| Annual Net Income | $12.50M | -90.8% | -79.3% | -72.3% | -51.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $607.80M | at high | |
| 5Y | $607.80M | at high | |
| All | $607.80M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $507.50M | N/A | +19.8% |
| 5Y | $322.10M | N/A | +88.7% |
| All | $72.53M | +738.0% |
EBITDA History
FAQ
What is the current annual EBITDA of SGRY?
As of today, SGRY annual EBITDA is $607.80M
What is 1-year change in SGRY annual EBITDA?
SGRY annual EBITDA is up +15.42% year-over-year
What is 3-year change in SGRY annual EBITDA?
SGRY annual EBITDA is up +42.51% over the past 3 years
How far is SGRY annual EBITDA from its all-time high?
SGRY annual EBITDA is currently at its all-time high
How does SGRY annual EBITDA rank versus sector peers?
SGRY annual EBITDA is higher than 92.27% of companies in Healthcare sector
When is SGRY next annual earnings release?
The next annual earnings release for SGRY is on
Quarterly EBITDA
$172.90M$13.40M+8.40%
Summary
- Current Value
- As of today, SGRY quarterly EBITDA is $172.90M, up +8.40% on
- Historical Performance
- SGRY quarterly EBITDA is up +16.59% year-over-year, and up +40.57% over the past 3 years
- All-Time High Comparison
- SGRY quarterly EBITDA is currently -12.50% below its historical high of $197.60M set on
- 3-Year Low Comparison
- SGRY quarterly EBITDA is +55.77% above its 3-year low of $111.00M reached on
- Sector Comparison
- SGRY quarterly EBITDA is higher than 91.04% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $172.90M | +8.4% | +16.6% | +40.6% | +75.9% | |
| Annual EBITDA | $607.80M | – | +15.4% | +42.5% | +62.0% | |
| TTM EBITDA | $655.90M | +3.9% | +12.7% | +38.8% | +106.8% | |
| Price | $16.12 | -20.7% | -24.1% | -43.6% | -46.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $821.50M | -0.6% | +6.6% | +32.4% | +65.6% | |
| Quarterly EPS | -$0.18 | -805.6% | +29.0% | +36.6% | +87.8% | |
| Quarterly EBIT | $133.40M | +11.9% | +36.0% | +59.8% | +105.5% | |
| Quarterly Net Income | $25.30M | -43.6% | +295.3% | +351.8% | +173.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $197.60M | N/A | -12.5% |
| 3Y | $197.60M | -12.5% | |
| 5Y | $197.60M | -12.5% | |
| All | $197.60M | -12.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $125.90M | +37.3% | |
| 3Y | $111.00M | +55.8% | |
| 5Y | $86.50M | +99.9% | |
| All | $19.27M | +797.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of SGRY?
As of today, SGRY quarterly EBITDA is $172.90M
What is SGRY quarterly EBITDA most recent change?
SGRY quarterly EBITDA was up +8.40% on September 30, 2025
What is 1-year change in SGRY quarterly EBITDA?
SGRY quarterly EBITDA is up +16.59% year-over-year
How far is SGRY quarterly EBITDA from its all-time high?
SGRY quarterly EBITDA is currently -12.50% below its historical high of $197.60M set on December 31, 2024
How does SGRY quarterly EBITDA rank versus sector peers?
SGRY quarterly EBITDA is higher than 91.04% of companies in Healthcare sector
When is SGRY next earnings release?
The next earnings release for SGRY is on
TTM EBITDA
$655.90M$24.60M+3.90%
Summary
- Current Value
- As of today, SGRY TTM EBITDA is $655.90M, up +3.90% on
- Historical Performance
- SGRY TTM EBITDA is up +12.70% year-over-year, and up +38.79% over the past 3 years
- All-Time High Comparison
- SGRY TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SGRY TTM EBITDA is +29.24% above its 3-year low of $507.50M reached on an earlier date
- Sector Comparison
- SGRY TTM EBITDA is higher than 91.49% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $655.90M | +3.9% | +12.7% | +38.8% | +106.8% | |
| Annual EBITDA | $607.80M | – | +15.4% | +42.5% | +62.0% | |
| Quarterly EBITDA | $172.90M | +8.4% | +16.6% | +40.6% | +75.9% | |
| Price | $16.12 | -20.7% | -24.1% | -43.6% | -46.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $3.29B | +1.6% | +10.1% | +34.6% | +79.8% | |
| TTM EPS | -$1.36 | +5.1% | -182.1% | -282.7% | +63.0% | |
| TTM EBIT | $505.90M | +7.5% | +17.1% | +53.7% | +170.4% | |
| TTM Net Income | $23.30M | +429.6% | -78.0% | -78.1% | +201.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $655.90M | at high | |
| 3Y | $655.90M | at high | |
| 5Y | $655.90M | at high | |
| All | $655.90M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $606.90M | N/A | +8.1% |
| 3Y | $507.50M | N/A | +29.2% |
| 5Y | $322.10M | N/A | +103.6% |
| All | $19.27M | +3303.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of SGRY?
As of today, SGRY TTM EBITDA is $655.90M
What is SGRY TTM EBITDA most recent change?
SGRY TTM EBITDA was up +3.90% on September 30, 2025
What is 1-year change in SGRY TTM EBITDA?
SGRY TTM EBITDA is up +12.70% year-over-year
How far is SGRY TTM EBITDA from its all-time high?
SGRY TTM EBITDA is currently at its all-time high
How does SGRY TTM EBITDA rank versus sector peers?
SGRY TTM EBITDA is higher than 91.49% of companies in Healthcare sector
When is SGRY next earnings release?
The next earnings release for SGRY is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- SGRY Official Website www.surgerypartners.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1638833/000163883325000163/0001638833-25-000163-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1638833/000163883325000053/0001638833-25-000053-index.htm
- SGRY Profile on Yahoo Finance finance.yahoo.com/quote/SGRY
- SGRY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgry